Literature DB >> 8292260

The covalent linkage of secretory component to IgA. Structure of sIgA.

E Fallgreen-Gebauer1, W Gebauer, A Bastian, H D Kratzin, H Eiffert, B Zimmermann, M Karas, N Hilschmann.   

Abstract

Immunoglobulin A which is secreted into external fluids is synthesized in plasma cells as an (IgA)2-J-chain complex. This complex docks on to the polyimmunoglobulin receptor which is located at the basolateral surface of epithelial cells. After docking the (IgA)2-J-receptor complex is internalized and processed. The polyimmunoglobulin receptor loses its C-terminal tail and thus becomes the secretory component. This secretory component is then covalently linked to the (IgA)2-J-chain complex by a disulfide bond, and protects the so formed sIgA from denaturation and proteolysis in external fluids. In order to establish this disulfide bond between IgA and the secretory component, sIgA, purified from human colostrum, was subjected to several enzymatic and chemical fragmentation reactions. One of the resulting polypeptides allowed us to characterize the covalent linkage of the secretory component to IgA in sIgA. IgA was found to be covalently linked to the secretory piece by a single disulfide bond between Cys 311 of one alpha-chain and Cys 467 of the secretory component. Cys 501 of the secretory component and Cys 311 of the other alpha-chain are blocked by cysteines. With this last paper of a series the structure of an entire sIgA molecule has been elucidated.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8292260     DOI: 10.1515/bchm3.1993.374.7-12.1023

Source DB:  PubMed          Journal:  Biol Chem Hoppe Seyler        ISSN: 0177-3593


  13 in total

Review 1.  The role of secretory antibodies in infection immunity.

Authors:  Richard A Strugnell; Odilia L C Wijburg
Journal:  Nat Rev Microbiol       Date:  2010-08-09       Impact factor: 60.633

2.  IgA and IgA-specific receptors in human disease: structural and functional insights into pathogenesis and therapeutic potential.

Authors:  Michelle M Gomes; Andrew B Herr
Journal:  Springer Semin Immunopathol       Date:  2006-10-17

3.  The nonplanar secretory IgA2 and near planar secretory IgA1 solution structures rationalize their different mucosal immune responses.

Authors:  Alexandra Bonner; Adel Almogren; Patricia B Furtado; Michael A Kerr; Stephen J Perkins
Journal:  J Biol Chem       Date:  2008-12-23       Impact factor: 5.157

Review 4.  Physiology of IgA and IgA deficiency.

Authors:  C Cunningham-Rundles
Journal:  J Clin Immunol       Date:  2001-09       Impact factor: 8.317

5.  Sequence of the dog immunoglobulin alpha and epsilon constant region genes.

Authors:  M Patel; D Selinger; G E Mark; G J Hickey; G F Hollis
Journal:  Immunogenetics       Date:  1995       Impact factor: 2.846

6.  A comparison of the binding of secretory component to immunoglobulin A (IgA) in human colostral S-IgA1 and S-IgA2.

Authors:  Adel Almogren; Bernard W Senior; Michael A Kerr
Journal:  Immunology       Date:  2006-11-29       Impact factor: 7.397

7.  A functional polymeric immunoglobulin receptor in chicken (Gallus gallus) indicates ancient role of secretory IgA in mucosal immunity.

Authors:  Willemien H Wieland; Diego Orzáez; Aart Lammers; Henk K Parmentier; Martin W A Verstegen; Arjen Schots
Journal:  Biochem J       Date:  2004-06-15       Impact factor: 3.857

8.  Structural insights into secretory immunoglobulin A and its interaction with a pneumococcal adhesin.

Authors:  Yuxin Wang; Guopeng Wang; Yaxin Li; Qinyu Zhu; Hao Shen; Ning Gao; Junyu Xiao
Journal:  Cell Res       Date:  2020-05-12       Impact factor: 25.617

9.  A comparison of anti-HER2 IgA and IgG1 in vivo efficacy is facilitated by high N-glycan sialylation of the IgA.

Authors:  Gerard Ja Rouwendal; Miranda M van der Lee; Saskia Meyer; Karli R Reiding; Jan Schouten; Guy de Roo; David F Egging; Jeanette Hw Leusen; Peter Boross; Manfred Wuhrer; Gijs F Verheijden; Wim H Dokter; Marco Timmers; Ruud Ubink
Journal:  MAbs       Date:  2015-10-06       Impact factor: 5.857

10.  Targeting mucosal sites by polymeric immunoglobulin receptor-directed peptides.

Authors:  Kendra D White; J Donald Capra
Journal:  J Exp Med       Date:  2002-08-19       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.